Dexketoprofen enhances NLRP3 activation via ATPase activity after canonical stimuli
Inflammopharmacology · 2025
DOI: 10.1007/s10787-025-01928-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, 2025. Verfasst von Daniel Boy-Ruiz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, 41013, Seville, Spain. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Ketoprofen, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía, Ministerio de Ciencia e Innovación, Universidad Pablo de Olavide.
Abstract (Originalsprache)
Inflammasomes are crucial elements of the innate immune system, responsible for triggering inflammation through the activation of caspase-1. Among them, the NLRP3 inflammasome plays a central role in various inflammatory and immune-related disorders. Dexketoprofen (DXK) is a widely used nonsteroidal anti-inflammatory drug (NSAID), although it has not been tested for its effects on the NLRP3 inflammasome pathway. In this study, we explored the influence of DXK on NLRP3 activation and its associated inflammatory responses in human macrophages. Our results showed that even at low concentrations, DXK enhances the release of IL-1β and promotes cell death upon stimulation with LPS and ATP, nigericin and LPS and nigericin, indicating it increases inflammasome activation. Docking and ATPase assays revealed that DXK binds to the NLRP3 NATCH domain, facilitating ATP hydrolysis and NLRP3 activation. Furthermore, treatment with DXK in combination with nigericin further increased IL-1β secretion, while the NLRP3 inhibitor MCC950 reduced the effects of DXK. These findings suggest that DXK amplifies inflammation in macrophages via NLRP3 activation, emphasizing the importance of caution in prolonged use, especially in autoinflammatory diseases where inflammasomes play a significant role. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, 41013, Seville, Spain.
- Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, 41013, Seville, Spain. mdcormor1@upo.es.
Förderung
- Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía
- Ministerio de Ciencia e Innovación
- Universidad Pablo de Olavide
Zitieren
APA
Boy-Ruiz, D., Suarez-Rivero, J. M., Muela-Zarzuela, I., & Cordero, M. D. (2025). Dexketoprofen enhances NLRP3 activation via ATPase activity after canonical stimuli. Inflammopharmacology. https://doi.org/10.1007/s10787-025-01928-2
Vancouver
Boy-Ruiz D, Suarez-Rivero JM, Muela-Zarzuela I, Cordero MD. Dexketoprofen enhances NLRP3 activation via ATPase activity after canonical stimuli. Inflammopharmacology. 2025. doi:10.1007/s10787-025-01928-2
BibTeX
@article{BoyRuiz2025,
author = {Boy-Ruiz, Daniel and Suarez-Rivero, Juan Miguel and Muela-Zarzuela, Inés and Cordero, Mario D},
title = {Dexketoprofen enhances NLRP3 activation via ATPase activity after canonical stimuli},
journal = {Inflammopharmacology},
year = {2025},
doi = {10.1007/s10787-025-01928-2}
}
EUVIMED